ALVOGEN, INC.

Entity uei:LJNNGDV77Y98 · UEI LJNNGDV77Y98 · parent: STROZ FRIEDBERG, LLC

About this data

Bounded ingest, not a census: 20,977 contract awards currently loaded (1,294 with full transaction history), per the scope in outlay.config.json. Totals are totals of the ingested set.
Dollar amounts are obligations — money the government has promised to pay, not cash already out the door. Agencies report this data themselves; the Defense Department publishes ~90 days late; the current budget year is still in progress. See methodology.
Source records republish silently; Outlay keeps its own append-only version archive from first pull onward. Post-publication revisions recorded so far: 0 awards (0 revisions). Revisions are routine (spending progresses, errors get corrected) and are not themselves evidence of anything.

Last ingest run #11 (failed) started Aug 5, 2026, 07:42 UTC — 0 awards, 0 details, 0 transactions.

Obligations by fiscal year

$227.7M


75A50325F80013 ↗ OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 47781-470-13); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 47781-468-13); 10 CT. BLISTERS PACKS.	Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	FY2025	Jun 30, 2025 – Jun 29, 2027	$227.7M	$227.7M	0

Raw recipient names from source records that resolved to this entity.